Cystic fibrosis, intravenous antibiotics, and home therapy.
The survival rate of patients with cystic fibrosis has improved considerably in the last 20 years. Although not all of the factors accounting for this change are understood, aggressive nutritional management and treatment of pulmonary exacerbations certainly play a role. Home intravenous (IV) antibiotic delivery for pulmonary exacerbation has proved to be as effective as hospital treatment and offers significant advantages to the patient and family. This article examines the microbiology of pulmonary infections in patients with cystic fibrosis, as well as antimicrobial therapy, methods of IV administration, home IV therapy, and the nurse practitioner's role in this home program in the future.
Hammond
L J
LJ
Caldwell
S
S
Campbell
P W
PW
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications*; D006699:Home Care Services; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing; D009722:Nurse Practitioners; D010353:Patient Education as Topic; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing
D000900:Anti-Bacterial Agents